Penumbra, Inc. (PEN)
324.77
+2.45
(+0.76%)
USD |
NYSE |
May 18, 11:21
Penumbra EPS Diluted (Quarterly) : 0.824 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.897 |
| Abbott Laboratories | 0.6165 |
| Insulet Corp. | 1.298 |
| Globus Medical, Inc. | 0.8995 |
| Intuitive Surgical, Inc. | 2.283 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 32.58M |
| Revenue (Quarterly) | 374.76M |
| Total Expenses (Quarterly) | 342.17M |
| Enterprise Value | 12.28B |
| Gross Profit Margin (Quarterly) | 66.42% |
| Profit Margin (Quarterly) | 8.69% |
| Earnings Yield | 1.34% |
| Operating Earnings Yield | 1.46% |
| Normalized Earnings Yield | 1.338 |